MTM(SH:688029) Xin Lang Cai Jing·2026-01-05 06:48Group 1 - The core viewpoint of the news is that Nanwei Medical has seen a 5% increase in stock price, reaching 85.64 yuan per share, with a total market capitalization of 16.087 billion yuan [1] - Nanwei Medical, established on May 10, 2000, specializes in the research, development, manufacturing, and sales of minimally invasive medical devices, with its main revenue sources being endoscopic consumables (77.80%), other categories (13.17%), tumor intervention (7.28%), visualization (1.00%), and others (0.74%) [1] Group 2 - From the perspective of major fund holdings, one fund under Rongtong has a significant position in Nanwei Medical, with 324,200 shares held, accounting for 3.88% of the fund's net value, making it the seventh-largest holding [2] - The Rongtong Healthcare Industry Mixed A/B Fund (161616) has a total scale of 708 million yuan and has achieved a year-to-date return of 7.26%, ranking 6303 out of 8155 in its category [2] Group 3 - The fund managers of Rongtong Healthcare Industry Mixed A/B are Wan Minyuan and Liu Xiyang, with Wan having a tenure of 9 years and 135 days and a total fund size of 5.957 billion yuan, achieving a best return of 130.09% during his tenure [3] - Liu Xiyang has a tenure of 1 year and 297 days with a fund size of 839 million yuan, with a best return of -7.72% during his tenure [3]